AAAAAA
Results:
1-8
|
Results: 8
Authors:
Miller, V
Vandamme, AM
Loveday, C
Staszewski, S
Lundgren, J
Youle, M
Ait-Khaled, M
Boucher, C
Brun-Vezinet, F
Dedes, N
Giaquinto, C
Hertogs, K
Houyez, F
Perrin, L
Pillay, D
Schmit, JC
Schuurman, R
Lange, J
Banhegyi, D
Biondi, G
Broekhuizen, A
Bush-Donovan, C
Camacho, R
Carlier, H
Clavel, F
Clotet, B
Clumeck, N
Colebunders, R
De Clerq, K
De Jaegher, JJ
De Schrijver, G
De Smet, K
Hall, W
Harrigan, R
Hatzakis, A
Hellmann, N
Hoetelmans, R
Holtzer, C
Katlama, C
Larder, D
Loriaux, E
McCreedy, B
Mulcahy, F
Opravil, M
Phillips, A
Ruiz, N
Shulse, E
Sonnerborg, A
Soriano, V
Steel, H
Vella, S
Williams, A
Citation: V. Miller et al., Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting, AIDS, 15(3), 2001, pp. 309-320
Authors:
DeGruttola, V
Dix, L
D'Aquila, R
Holder, D
Phillips, A
Ait-Khaled, M
Baxter, J
Clevenbergh, P
Hammer, S
Harrigan, R
Katzenstein, D
Lanier, R
Miller, M
Para, M
Yerly, S
Zolopa, A
Murray, J
Patick, A
Miller, V
Castillo, S
Pedneault, L
Mellors, J
Citation: V. Degruttola et al., The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan, ANTIVIR TH, 5(1), 2000, pp. 41-48
Authors:
Tisdale, M
Myers, R
Randall, S
Maguire, M
Ait-Khaled, M
Elston, R
Snowden, W
Citation: M. Tisdale et al., Resistance to the HIV protease inhibitor amprenavir in vitro and in clinical studies - A review, CLIN DRUG I, 20(4), 2000, pp. 267-285
Authors:
Katlama, C
Clotet, B
Plettenberg, A
Jost, J
Arasteh, K
Bernasconi, E
Jeantils, V
Cutrell, A
Stone, C
Ait-Khaled, M
Purdon, S
Citation: C. Katlama et al., The role of abacavir (ABC, 1592) in antiretroviral therapy-experienced patients: results from a randomized, double-blind, trial, AIDS, 14(7), 2000, pp. 781-789
Authors:
Miller, V
Ait-Khaled, M
Stone, C
Griffin, P
Mesogiti, D
Cutrell, A
Harrigan, R
Staszewski, S
Katlama, C
Pearce, G
Tisdale, M
Citation: V. Miller et al., HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy, AIDS, 14(2), 2000, pp. 163-171
Authors:
Rakik, A
Ait-Khaled, M
Griffin, P
Thomas, DA
Tisdale, M
Kleim, JP
Citation: A. Rakik et al., A novel genotype encoding a single amino acid insertion and five other substitutions between residues 64 and 74 of the HIV-1 reverse transcriptase confers high-level cross-resistance to nucleoside reverse transcriptase inhibitors, J ACQ IMM D, 22(2), 1999, pp. 139-145
Authors:
Griffiths, PD
Ait-Khaled, M
Bearcroft, CP
Clark, DA
Quaglia, A
Davies, SE
Burroughs, AK
Rolles, K
Kidd, IM
Knight, SN
Noibi, SM
Cope, AV
Phillips, AN
Emery, VC
Citation: Pd. Griffiths et al., Human herpesviruses 6 and 7 as potential pathogens after liver transplant:Prospective comparison with the effect of cytomegalovirus, J MED VIROL, 59(4), 1999, pp. 496-501
Authors:
Clarke, JR
Braganza, R
Mirza, A
Stainsby, C
Ait-Khaled, M
Wright, A
Lyall, H
Parker, D
McClure, MO
Weber, JN
Taylor, GP
Citation: Jr. Clarke et al., Rapid development of genotypic resistance to lamivudine when combined withzidovudine in pregnancy, J MED VIROL, 59(3), 1999, pp. 364-368
Risultati:
1-8
|